1 / 27

Disparities in Universal Prenatal Screening for Group B Streptococcus North Carolina, 2002-2003

Disparities in Universal Prenatal Screening for Group B Streptococcus North Carolina, 2002-2003. Heidi Brown 1 , Stephanie Schrag 2 , Matt Avery 3 1 – Brown Medical School, CDC Experience Fellow

lala
Télécharger la présentation

Disparities in Universal Prenatal Screening for Group B Streptococcus North Carolina, 2002-2003

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Disparities in Universal Prenatal Screening for Group B Streptococcus North Carolina, 2002-2003 Heidi Brown1, Stephanie Schrag2, Matt Avery3 1 – Brown Medical School, CDC Experience Fellow 2 – National Center for Infectious Diseases, Division of Bacterial & Mycotic Diseases, Respiratory Diseases Branch 3 – North Carolina State Center for Health Statistics

  2. Overview • What is group B strep? • How are we doing with universal screening? • How many? • Who? • How can we do better?

  3. Streptococcus agalactiaeGroup B streptococcus (GBS) Leading infectious cause of neonatal morbidity & mortality NEONATAL GBS: • Timing & Transmission: • Early-onset (<7 days old) - intrapartum • Late-onset (7 – 90 days old) - neonatal • Manifestations: • sepsis • pneumonia • meningitis

  4. Mother to Infant GBS Transmission 10 – 35% GBS colonized mother 50% 50% Non-colonized newborn Colonized newborn 98% 2% Early-onset sepsis, pneumonia, meningitis Asymptomatic 5% Neurologic sequelae Death

  5. Prevention of Perinatal Transmission Intrapartum Antibiotics GBS colonized mother 50% 50% Non-colonized newborn Colonized newborn 98% 2% Early-onset sepsis, pneumonia, meningitis Asymptomatic 5% Neurologic sequelae Death

  6. Who should get antibiotics? 1996: 2 equally acceptable strategies 1) late prenatal culture-based GBS screening - if GBS+, then antibiotics administered 2) prophylactic antibiotics to any woman with defined risk factors for GBS colonization or transmission

  7. Policy Change! 2002: NEJM retrospective cohort study Screening >50% more effective than risk-based 2002: CDC, AAP, ACOG - updated guidelines: UNIVERSAL culture-based screening for vaginal and rectal GBS colonization at 35-37 weeks’ gestation

  8. Objectives • Among pregnant women in North Carolina during 2002-2003, to: 1) examine rates of reported GBS screening and knowledge of GBS screening status 2) identify risk factors for: a) not being screened for GBS b) lack of knowledge of GBS screening status

  9. Pregnancy Risk AssessmentMonitoring System (PRAMS) • Monthly mail / telephone survey • Population-based, random, stratified sample • Women who have recently delivered a liveborn infant • Core & standard questions • 3 GBS questions in standard / optional component

  10. Pregnancy Risk AssessmentMonitoring System (PRAMS) • Survey data linked to birth certificate data • Weighted for sample design, nonresponse, and noncoverage • > 70% response rate  usable data • 2 year lag between data collection and availability

  11. Participating PRAMS States

  12. Data Analysis • North Carolina PRAMS 2002 & 2003 • 2002 & 2003 similar  combined data • “At any time during your most recent pregnancy, did you get tested for the bacteria Group B Strep (or Beta Strep)?” • Yes • No • I don’t know

  13. Data Analysis • Point estimates & 95% confidence intervals (CIs) calculated for: • “No” vs. “Yes” – excluding “I don’t know” • “I don’t know” vs. “Yes” – excluding “No” • Univariate analysis p<0.2  initial multivariable models • Logistic regression • Main effects p<0.05  final multivariable models

  14. Results - Demographics • 235,599 live births in North Carolina • 4,128 women included in PRAMS sample • 3,027 responded (73%) • 73% White, 22% Black, 5% Other • 12% Hispanic ethnicity • 49% Delivery paid by Medicaid • Primary Source of Prenatal Care: • 68% Private doctor / HMO • 28% Hospital or health department clinic • <1% no prenatal care

  15. Results – Prenatal Screening • 82% received HIV testing during pregnancy • 82% healthcare worker discussed GBS

  16. Lack of GBS Screening among Women with Known Screening Status • Age <24 years • < High school education • Hispanic ethnicity • Unmarried • Delivery paid by Medicaid • Prenatal care at clinic or elsewhere • No insurance before pregnancy • Lack of prenatal HIV testing

  17. Lack of GBS Screening among Women with Known Screening Status AOR (95% CI) • Age <24 years • < High school education • Hispanic ethnicity 0.3 (0.2 – 0.5) • Unmarried • Delivery paid by Medicaid • Prenatal care at clinic or elsewhere 0.6 (0.4 – 0.9) • No insurance before pregnancy • Lack of prenatal HIV testing 0.4 (0.3 – 0.6) controlled for gestational age

  18. Lack of Knowledge of GBS screening status, compared with screened women • Age <24 years • < High school education • Hispanic ethnicity • Unmarried • Delivery paid by Medicaid • Prenatal care at clinic or elsewhere • No insurance before pregnancy • Lack of prenatal HIV testing • Black race (versus White) • Other race (versus White) • Unintended pregnancy • Receipt of WIC benefits during pregnancy

  19. Lack of Knowledge of GBS screening status, compared with screened women AOR (95% CI) • Age <24 years • < High school education • Hispanic ethnicity 0.1 (0.1 – 0.2) • Unmarried • Delivery paid by Medicaid 0.4 (0.3 – 0.5) • Prenatal care at clinic or elsewhere 0.5 (0.4 – 0.7) • No insurance before pregnancy • Lack of prenatal HIV testing 0.6 (0.4 – 1.0) • Black race (versus White) 0.6 (0.4 – 0.8) • Other race (versus White) 0.3 (0.2 – 0.5) • Unintended pregnancy • Receipt of WIC benefits during pregnancy

  20. Summary – No GBS Screening • Among women participating in North Carolina PRAMS during 2002-2003: • 72% were screened for GBS during pregnancy • Risk factors for lack of screening: • Hispanic ethnicity • Prenatal care from hospital / health department clinic • Lack of prenatal HIV test

  21. Summary – Unknown GBS Screening • 19% did not know GBS screening status • Risk factors for lack of knowledge: • Hispanic ethnicity • Prenatal care from hospital / health department clinic • Lack of prenatal HIV test • Black race or other race • Delivery paid for by Medicaid

  22. Limitations • Self-reported survey so GBS screening status cannot be confirmed • Healthcare providers might not use same wording as PRAMS question • Cannot generalize findings to entire country • No baseline data with which to compare screening rates

  23. What does it all mean? 1996 2002 Healthy People 2010 early - onset late - onset Data from ABCs (national projections of invasive disease)

  24. Discussion: Linking Data and Policy to Programs • How can we prevent missed opportunities for prevention? • Two-pronged approach: • encourage prenatal care providers to screen women for and educate women about GBS • educate pregnant women so that they may ask for prenatal screening and discuss their GBS status with labor & delivery staff • How can we improve perinatal GBS prevention in NC? • Target efforts to minimize disparities • Hispanic women • Women who miss other recommended prenatal interventions • Hospital / health department clinics

  25. Targeting Messages

  26. Program Materials Available from CDC • Brochures available in English and Spanish • http://www.cdc.gov/groupbstrep/ • For limited copies, call 404-639-2215 (CDC) • For bulk orders, call 1-877-252-1200

  27. Acknowledgments North Carolina State Center for Health Statistics • M. Avery • P. Buescher • Z. Gizlice CDC/NCID/DBMD/RDB • S. Schrag • J. Cory • C. Greene

More Related